Nootrion
EN
Longevity & Anti-Aging

Basic Longevity Protocol (Ages 35–45): 8 Core Supplements and a 3‑Month Start Plan

A practical, budget‑aware supplement protocol for people aged 35–45 who want a sensible longevity foundation. Eight core supplements, why they matter, typical doses, safety notes and a phased 3‑month rollout with simple checkpoints to track sleep, muscle and metabolic signals.

Published 8 min read

Language:NederlandsDeutschFrançaisEspañolPortuguês

For information only. Not a substitute for professional medical advice. Medical disclaimer

Several supplement bottles and blister packs laid out beside a notepad with a three-month plan and a pen

If you’re between 35 and 45 and want a no‑nonsense longevity supplement foundation without chasing expensive trends, this is a pragmatic starter plan. I list eight supplements I consider the skeleton of a basic protocol, the priority order to introduce them over three months, doses you can actually use, and simple checkpoints to measure whether they’re helping.

Executive summary: the 8 essentials (and why they belong in the base)

  • Vitamin D3 (with K2 MK‑7): foundational for bone, muscle and calcium balance; start supplementation after checking serum 25(OH)D. ⚠️ Note: K2 interferes with vitamin K antagonist anticoagulants (e.g., warfarin) and may be contraindicated or require strict medical monitoring. (ods.od.nih.gov)
  • Omega‑3 (EPA+DHA): cardiovascular and anti‑inflammatory support at low cost/risk; 1–2 g/day.
  • Magnesium (glycinate/citrate): closes common dietary gaps and can help blood pressure and sleep.
  • Creatine monohydrate: preserves strength/muscle (and possibly cognition); 3–5 g/day.
  • Soluble fiber (psyllium): lowers LDL‑C and improves post‑meal glycemia; 7–10 g/day.
  • Targeted multivitamin (no megadoses): covers typical micronutrient shortfalls (vitamin D, iodine, selenium, zinc).
  • Glycine: 3 g at bedtime may improve sleep quality and reduce daytime fatigue.
  • Optional NAD+ block (advanced): resveratrol (100–300 mg/day) or NR/Niagen (300–500 mg/day) — pick one; human evidence is mixed so treat as experimental.

Phased 3‑month implementation (priorities, checkpoints and adherence)

Phased rollout to minimise cost, test tolerance and measure early effects.
WhenAddWhy nowHow to measure (8–12 weeks)Cost‑benefit
Month 1 (Weeks 1–4)D3+K2; Omega‑3; Magnesium; PsylliumCover frequent gaps with high evidence/cost ratio.Serum 25(OH)D; lipid profile (LDL‑C); home BP 2–3x/week; bowel consistency (Bristol).Very high
Month 2 (Weeks 5–8)Creatine; Targeted multivitaminConsolidate muscle and micronutrients without increasing pill burden too much.Strength tests (squat/push‑ups max), weight/measurements; review multi label (no megadoses).High
Month 3 (Weeks 9–12)Glycine (sleep); Resveratrol or NR (one only)Advanced layer: sleep and cellular metabolism; introduce one at a time.Sleep diary + actigraphy/smartwatch; home BP/arterial stiffness if available; subjective wellbeing (0–10).Medium

The supplements, one by one (what they are, dose, when to take, pros/cons, cost)

1) Vitamin D3 + K2 (MK‑7) — the anchor of the base

What it is and what it does: vitamin D regulates calcium/phosphate metabolism, muscle and immunity; K2 helps direct calcium to bone rather than soft tissues. Many adults reach adequate status with serum 25(OH)D ≥20 ng/mL (50 nmol/L). (ods.od.nih.gov)

Typical dose and timing: D3 1,000–2,000 IU/day (adjust after testing) with a fatty meal; K2 MK‑7 90–180 mcg/day. Avoid exceeding 4,000 IU/day without clinical indication. (ncbi.nlm.nih.gov)

Safety note: K2 can counteract vitamin K antagonist anticoagulants (e.g., warfarin). Don’t add K2 without discussing your medications with a clinician.

Pros/cons: corrects deficiency readily; K2 showed improvements in arterial stiffness in some contexts (post‑menopausal RCT) but results are heterogeneous. (pubmed.ncbi.nlm.nih.gov)

Cost‑benefit: high (low cost, meaningful impact when deficiency exists).

2) Omega‑3 (EPA+DHA) — safe, practical and consistent

What it is and what it does: EPA and DHA are essential fatty acids tied to cardiovascular health and inflammation modulation. Increasing intake via fatty fish or supplements is the practical route to raise tissue levels. (ods.od.nih.gov)

Typical dose and timing: 1–2 g/day combined EPA+DHA with a meal; practical safety threshold <3 g/day. (ods.od.nih.gov)

Pros/cons: generally well tolerated; some people experience fishy reflux — enteric‑coated or re‑esterified products can help.

Cost‑benefit: high.

3) Magnesium (glycinate/citrate) — the gap‑closing mineral

What it is and what it does: magnesium is a cofactor in 300+ enzymatic reactions; intake is often suboptimal and meta‑analyses suggest modest BP reductions with supplementation. (ods.od.nih.gov)

Typical dose and timing: 200–400 mg/day elemental magnesium, preferably at night. Glycinate is gentler; citrate has stronger laxative effects.

Pros/cons: may help cramps, muscle tension and sleep for some; can loosen stools — reduce dose if needed.

Cost‑benefit: high.

4) Creatine monohydrate — muscle today, resilience tomorrow

What it is and what it does: creatine increases muscle phosphocreatine stores, improving strength and power, and helps maintain lean mass with age. The ISSN supports its safety and efficacy. (pmc.ncbi.nlm.nih.gov)

Typical dose and timing: 3–5 g/day (no loading required). Timing during the day is flexible; take with a meal or drink.

Pros/cons: expect ~1–2 kg water gain inside cells (normal). If you have known kidney disease, consult your doctor. (link.springer.com)

Cost‑benefit: very high (pennies per day).

5) Soluble fiber (psyllium) — cholesterol and glycemia under control

What it is and what it does: psyllium is a soluble fibre that meta‑analyses show lowers LDL‑C by roughly 7% (~13 mg/dL) and improves non‑HDL and apoB when taken around ~10 g/day. The FDA recognises a health claim for psyllium and CHD risk. (ajcn.nutrition.org)

Typical dose and timing: 5–10 g/day divided, 15–30 min before meals with 250–300 ml water; separate from medications by 2–4 hours.

Pros/cons: initial bloating possible — increase gradually.

Cost‑benefit: very high.

6) Targeted multivitamin — no megadoses, focus on gaps

What it is and what it does: not a panacea, but useful to cover common deficits. The Dietary Guidelines highlight vitamin D, calcium, potassium and fiber as nutrients of public health concern (fiber preferably from food). (dietaryguidelines.gov)

How to pick one: aim for ~100% of the daily reference value (DRV) for most micronutrients; avoid megadoses of vitamins A/D/E/K; include iodine (~150 mcg), selenium (~55 mcg) and zinc (8–11 mg). Take with breakfast.

Cost‑benefit: medium‑high (varies by formula).

7) Glycine — low‑cost sleep and recovery aid

What it is and what it does: an amino acid that, in small trials (3 g at bedtime), improved sleep quality and reduced daytime fatigue. It’s not a sedative; it may smooth the transition to sleep. (onlinelibrary.wiley.com)

Typical dose and timing: 3 g 30–60 min before bed; mildly sweet taste, mixes into drinks.

Pros/cons: favourable safety profile at usual doses; evidence is still limited in duration and sample size.

Cost‑benefit: high.

8) NAD+ block (optional/advanced): Resveratrol or NR (pick one)

What it is and what it does: the concept is to support cellular/mitochondrial signalling. Human results are mixed. Resveratrol produced calorie‑restriction‑like signals in one trial at 150 mg/day for 30 days in obese men, but other studies failed to show robust metabolic benefits. (pubmed.ncbi.nlm.nih.gov)

Nicotinamide riboside (NR) raises NAD+ in humans and was well tolerated in middle‑aged adults; there are exploratory signals for arterial stiffness/BP but more trials are needed. Common dose: 300–500 mg/day. (doi.org)

Regulatory note: public FDA documents indicate NMN (a relative of NR) is not clearly excluded from the definition of a dietary supplement; check local status and supplier quality. (downloads.regulations.gov)

How to choose: budget‑constrained → resveratrol 100–300 mg/day with a fatty meal; curious/able to spend more → NR. Don’t mix with megadoses of niacin.

Cost‑benefit: medium/low — treat as a bonus after the base is established.

Adjustments by budget and lifestyle

  • If you must cut, keep D3+K2, omega‑3, magnesium and psyllium; add creatine when feasible; leave the NAD+ block for last.
  • Vegan/vegetarian: use algal omega‑3 (EPA+DHA) at the same dose.
  • If you take statins: consider discussing CoQ10 with your clinician (not part of the top‑8 base, but sometimes helps myalgias).
  • Quarterly checklist: tests (25(OH)D; lipids; fasting glucose/BP), adherence (>80% of doses), symptoms (sleep, energy, bowel), and budget.

How to reduce capsule count (without losing efficacy)

  • Buy D3 combined with K2 (MK‑7) at the desired dose.
  • Choose concentrated omega‑3 capsules (e.g., 1 g EPA+DHA per capsule) to lower pill number.
  • Psyllium powder (1–2 scoops/day) replaces multiple fibre pills.
  • Creatine powder mixes easily into morning coffee or a shake.

Sources

  1. Vitamin D — Health Professional Fact Sheet (NIH ODS) — Níveis séricos e RDA/UL para adultos; base para alvo ≥20 ng/mL e UL 4.000 UI/dia.
  2. Tolerable Upper Intake Levels for Vitamin D (IOM/NASEM) — Justificação do UL de 4.000 UI/dia em adultos.
  3. Omega‑3 Fatty Acids — Health Professional Fact Sheet (NIH ODS) — Contexto de EPA+DHA e benefícios.
  4. Omega‑3 Fatty Acids — Consumer (NIH ODS) — Limite prático de segurança: ≤3 g/d EPA+DHA (até 2 g de suplementos).
  5. ISSN Position Stand: Safety and efficacy of creatine (2017) — Dose típica 3–5 g/dia e perfil de segurança.
  6. FDA: Authorized Health Claims that Meet the SSA Standard — Health claim para fibra solúvel (psyllium) e risco de CHD.
  7. Magnesium — Health Professional Fact Sheet (NIH ODS) — Efeito modesto na PA em meta‑análises; segurança/doses.
  8. Umbrella meta‑analysis de RCTs: magnésio e pressão arterial (2024) — Síntese recente com resultados heterogéneos, efeito global pequeno.
  9. Glycine improves sleep quality — RCTs (2006, 2007) — 3 g ao deitar melhorou medidas subjetivas/objetivas de sono.
  10. Daytime performance under sleep restriction improved with 3 g glycine — RCT — Menos fadiga/sonolência diurna com glicina.
  11. Dietary Guidelines for Americans 2020–2025 (USDA/HHS) — Nutrientes de preocupação pública: vitamina D, cálcio, potássio e fibra.
  12. Resveratrol 150 mg/d por 30 dias — efeitos tipo restrição calórica (Cell Metabolism, 2011) — Ensaio preliminar em homens obesos.
  13. Alta dose de resveratrol sem benefício metabólico (Diabetes, 2013) — Falha em melhorar sensibilidade à insulina/PA em obesos.
  14. Sem benefícios claros do resveratrol na síndrome metabólica (JCEM, 2017) — Resultados inconsistentes em humanos.
  15. Nicotinamide riboside eleva NAD+ e é bem tolerado (Nature Communications, 2018) — Sinais exploratórios em PA/rigidez arterial; precisa de mais estudos.
  16. Vitamina K2 (MK‑7) 180 mcg/d por 3 anos reduziu rigidez arterial em pós‑menopausa (RCT) — Resultado não universal a todas as populações.
  17. Vitamina K2 não melhorou rigidez arterial em DRC (RCT) — Exemplo de resultado negativo — utilidade depende do contexto.
  18. FDA (2024/2025): documentos públicos sobre estatuto de NMN — Linguagem indica que NMN não está excluído da definição de suplemento; verificar sempre estado mais recente.
  19. FDA: NDI Guidance e enquadramento regulatório de suplementos — Contexto sobre notificações de novos ingredientes.

Sources listed by the authors. Always confirm information with a healthcare professional.